{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:49:48Z","timestamp":1789487388872,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,15]]},"DOI":"10.7759\/cureus.116277","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:00:17Z","timestamp":1789480817000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond Prognosis: A Systematic Review of the Neutrophil-to-Lymphocyte Ratio as a Modifiable Cardiovascular Biomarker"],"prefix":"10.7759","author":[{"given":"Yousof","family":"Alemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad K","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad S","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Habeeb Ur Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice D","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Prabakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeyza","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali H","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jch.70172","article-title":"Targeted anti-inflammatory therapy in cardiovascular events: challenges and opportunities","volume":"27","author":"Ma T","year":"2025","unstructured":"Ma T, Wang L, Yan X, Li F. Targeted anti-inflammatory therapy in cardiovascular events: challenges and opportunities. J Clin Hypertens (Greenwich). 2025, 27:e70172. 10.1111\/jch.70172","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118608","article-title":"Immune cell dynamics and their role in cardiac injury: mechanisms and therapeutic implications","volume":"192","author":"Liu C","year":"2025","unstructured":"Liu C, Wu R, Yang H, Yao Y. Immune cell dynamics and their role in cardiac injury: mechanisms and therapeutic implications. Biomed Pharmacother. 2025, 192:118608. 10.1016\/j.biopha.2025.118608","journal-title":"Biomed Pharmacother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073636","article-title":"Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases","volume":"23","author":"Buonacera A","year":"2022","unstructured":"Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. 2022, 23:10.3390\/ijms23073636","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178256","article-title":"Silent inflammation, loud consequences: decoding NLR across renal, cardiovascular and metabolic disorders","volume":"26","author":"Carollo C","year":"2025","unstructured":"Carollo C, Sorce A, Cirafici E, Ciuppa ME, Mul\u00e8 G, Caimi G. Silent inflammation, loud consequences: decoding NLR across renal, cardiovascular and metabolic disorders. Int J Mol Sci. 2025, 26:10.3390\/ijms26178256","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85373-5","article-title":"Prognostic value of neutrophil to lymphocyte ratio in acute ischemic stroke after reperfusion therapy","volume":"11","author":"Bi Y","year":"2021","unstructured":"Bi Y, Shen J, Chen SC, Chen JX, Xia YP. Prognostic value of neutrophil to lymphocyte ratio in acute ischemic stroke after reperfusion therapy. Sci Rep. 2021, 11:6177. 10.1038\/s41598-021-85373-5","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.2165","article-title":"The Cochrane Risk of Bias assessment tool 2 (RoB 2) versus the original RoB: a perspective on the pros and cons","volume":"7","author":"Nejadghaderi SA","year":"2024","unstructured":"Nejadghaderi SA, Balibegloo M, Rezaei N. The Cochrane Risk of Bias assessment tool 2 (RoB 2) versus the original RoB: a perspective on the pros and cons. Health Sci Rep. 2024, 7:e2165. 10.1002\/hsr2.2165","journal-title":"Health Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden JA","year":"2013","unstructured":"Hayden JA, van der Windt DA, Cartwright JL, C\u00f4t\u00e9 P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013, 158:280-6. 10.7326\/0003-4819-158-4-201302190-00009","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.4277","article-title":"Association of interleukin 6 inhibition with ziltivekimab and the neutrophil-lymphocyte ratio: a secondary analysis of the rescue clinical trial","volume":"8","author":"Adamstein NH","year":"2023","unstructured":"Adamstein NH, Cornel JH, Davidson M, et al.. Association of interleukin 6 inhibition with ziltivekimab and the neutrophil-lymphocyte ratio: a secondary analysis of the rescue clinical trial. JAMA Cardiol. 2023, 8:177-81. 10.1001\/jamacardio.2022.4277","journal-title":"JAMA Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41387-025-00360-3","article-title":"Effect of long-term Mediterranean versus low-fat diet on neutrophil count, and type 2 diabetes mellitus remission in patients with coronary heart disease: results from the CORDIOPREV study","volume":"15","author":"Boughanem H","year":"2025","unstructured":"Boughanem H, Gutierrez-Mariscal FM, Arenas-de Larriva AP, et al.. Effect of long-term Mediterranean versus low-fat diet on neutrophil count, and type 2 diabetes mellitus remission in patients with coronary heart disease: results from the CORDIOPREV study. Nutr Diabetes. 2025, 15:11. 10.1038\/s41387-025-00360-3","journal-title":"Nutr Diabetes"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-03042-7","article-title":"Timing-dependent anti-inflammatory effects of empagliflozin in monocyte-derived macrophages from post-myocardial infarct patients with type 2 diabetes","volume":"25","author":"Cliff CL","year":"2026","unstructured":"Cliff CL, Shah MU, Ward JK, Inghels M, Lee K, Squires PE, Hills CE. Timing-dependent anti-inflammatory effects of empagliflozin in monocyte-derived macrophages from post-myocardial infarct patients with type 2 diabetes. Cardiovasc Diabetol. 2026, 25:43. 10.1186\/s12933-025-03042-7","journal-title":"Cardiovasc Diabetol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27093854","article-title":"Curcumin supplementation reduces inflammation, neutrophil-to-lymphocyte ratio (NLR), and antioxidant status in obese patients with type 2 diabetes: a randomized controlled trial","volume":"27","author":"Yaikwawong M","year":"2026","unstructured":"Yaikwawong M, Kamdee K, Chuengsamarn S. Curcumin supplementation reduces inflammation, neutrophil-to-lymphocyte ratio (NLR), and antioxidant status in obese patients with type 2 diabetes: a randomized controlled trial. Int J Mol Sci. 2026, 27:10.3390\/ijms27093854","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.041825","article-title":"Normobaric hyperoxia in patients with acute stroke: enhancing neuroprotection through inhibition of inflammation","volume":"15","author":"Niu H","year":"2026","unstructured":"Niu H, Ding J, Chen Z, Yuan S, Qi Z, Ji X, Li W. Normobaric hyperoxia in patients with acute stroke: enhancing neuroprotection through inhibition of inflammation. J Am Heart Assoc. 2026, 15:e041825. 10.1161\/JAHA.125.041825","journal-title":"J Am Heart Assoc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-024-04022-7","article-title":"Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy","volume":"24","author":"Dihoum A","year":"2024","unstructured":"Dihoum A, Brown AJ, McCrimmon RJ, Lang CC, Mordi IR. Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy. BMC Cardiovasc Disord. 2024, 24:356. 10.1186\/s12872-024-04022-7","journal-title":"BMC Cardiovasc Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.048092","article-title":"Effect of 2 weeks of time-restricted eating on innate immunity and systemic inflammation in patients with a history of myocardial infarction: a randomized-controlled crossover study","volume":"15","author":"Los J","year":"2026","unstructured":"Los J, Broeders W, Bahrar H, et al.. Effect of 2 weeks of time-restricted eating on innate immunity and systemic inflammation in patients with a history of myocardial infarction: a randomized-controlled crossover study. J Am Heart Assoc. 2026, 15:e048092. 10.1161\/JAHA.125.048092","journal-title":"J Am Heart Assoc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01904-6","article-title":"Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction - a post-hoc analysis of the EMMY trial","volume":"22","author":"Benedikt M","year":"2023","unstructured":"Benedikt M, Mangge H, Aziz F, et al.. Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction - a post-hoc analysis of the EMMY trial. Cardiovasc Diabetol. 2023, 22:166. 10.1186\/s12933-023-01904-6","journal-title":"Cardiovasc Diabetol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.030071","article-title":"Regression of coronary fatty plaque and risk of cardiac events according to blood pressure status: data from a randomized trial of eicosapentaenoic acid and docosahexaenoic acid in patients with coronary artery disease","volume":"12","author":"Welty FK","year":"2023","unstructured":"Welty FK, Hariri E, Asbeutah AA, et al.. Regression of coronary fatty plaque and risk of cardiac events according to blood pressure status: data from a randomized trial of eicosapentaenoic acid and docosahexaenoic acid in patients with coronary artery disease. J Am Heart Assoc. 2023, 12:e030071. 10.1161\/JAHA.123.030071","journal-title":"J Am Heart Assoc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/MCA.0000000000001295","article-title":"Effects of cardiac rehabilitation on inflammatory biomarkers in unstable ischemic heart disease patients following percutaneous coronary intervention: a randomized controlled study","volume":"35","author":"Awada M","year":"2024","unstructured":"Awada M, Sanaei S, Jameie M, Rahnamoun Z. Effects of cardiac rehabilitation on inflammatory biomarkers in unstable ischemic heart disease patients following percutaneous coronary intervention: a randomized controlled study. Coron Artery Dis. 2024, 35:8-13. 10.1097\/MCA.0000000000001295","journal-title":"Coron Artery Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.020560","article-title":"Glutathione infusion before and 3 days after primary angioplasty blunts ongoing NOX2-mediated inflammatory response","volume":"10","author":"Tanzilli G","year":"2021","unstructured":"Tanzilli G, Arrivi A, Placanica A, et al.. Glutathione infusion before and 3 days after primary angioplasty blunts ongoing NOX2-mediated inflammatory response. J Am Heart Assoc. 2021, 10:e020560. 10.1161\/JAHA.120.020560","journal-title":"J Am Heart Assoc"},{"key":"ref20","article-title":"The effects of bivalirudin and ordinary heparin on the incidence of bleeding events and the level of inflammation after interventional therapy for acute myocardial infarction","volume":"31","author":"Wu Q","year":"2025","unstructured":"Wu Q, Xie T, Chen Y, Zhou Y, Han X. The effects of bivalirudin and ordinary heparin on the incidence of bleeding events and the level of inflammation after interventional therapy for acute myocardial infarction. Altern Ther Health Med. 2025, 31:96-101.","journal-title":"Altern Ther Health Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/524427-beyond-prognosis-a-systematic-review-of-the-neutrophil-to-lymphocyte-ratio-as-a-modifiable-cardiovascular-biomarker","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:00:18Z","timestamp":1789480818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/524427-beyond-prognosis-a-systematic-review-of-the-neutrophil-to-lymphocyte-ratio-as-a-modifiable-cardiovascular-biomarker"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.116277","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}